Please login to the form below
Generics UK
This page shows the latest Generics UK news and features for those working in and with pharma, biotech and healthcare.
NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access
Speaking at a UK market access summit hosted by IQVIA in London, Blake Dark said he was still in the early days of his post, and was listening to industry views ... and the company’s generics division, with his last role being co-ordinator of
Latest news
-
Warning ‘at red’ on no deal Brexit medicines chaos
The UK pharma, biotech and generics medicines associations and the NHS’ Brexit Health Alliance and others have now called for an urgent meeting with the health secretary Matt Hancock, and say ... The EU says an agreement must be reached by the
-
Lilly wins on appeal in Alimta vitamin regimen dispute
The ruling finds that Actavis generics on sale in the UK, France, Italy and Spain infringe on Lilly's patents for Alimta (pemetrexed disodium), which has lost patent protection in several ... directly infringe the patents, a decision which was upheld the
-
Teva sells UK and Ireland assets to Intas Pharma for £603m
Generics portfolio and manufacturing facility gain set to double Indian firm’s UK sales. ... Offloading Actavis Generics UK and Irish assets is the latest in a series of divestments by Teva to meet antitrust conditions from international regulatory
-
Lundbeck challenge to EC pay-for-delay ruling fails
Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... The four generics companies - Generics UK, Arrow, Alpharma and Ranbaxy - were fined around 52m, and those judgments have also been upheld by the General Court of the EU.
-
UK government fines GSK over 'pay-for-delay' deals
Actavis which have both been fined for the involvement of various generics units. ... Former Merck subsidiary Generics (UK) Ltd and Alpharma (acquired by Actavis in 2005) had been sued by GSK for patent infringement but the cases were dropped after the
More from news
Approximately 3 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Mylan sees the UK paving the way for an insulin game changer
The fertile UK landscape is an alluring springboard for biosimilars, with Mylan recording strong uptakes in previous launches. ... biosimilars. “The UK can take the lead on showing other countries how to properly manage the opportunity of
-
Deal Watch October 2016
Similarly the acquisition of Actavis (Allergan) Generics by Teva for $40.5bn has resulted in the divestment of Actavis's former factory and some products in the UK and Ireland to ... Teva (IS). Intas (IN). Asset Acquisition. Former Actavis generics
-
Pharma deals during January 2015
This deal was of significance to Actavis as it gives the company the number 1 position for generics in the UK.
-
Proving value in uncertain times
Additional pressure is being exerted in many EU markets with the introduction of new, additional barriers to access, whether it's the idea of value-based pricing in the UK or ... officially sanctioned generics prescribing targets in markets such as Spain,
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Teva appoints UK & Ireland general manager
Promotes UK chief operating officer Kim Innes. Teva UK has promoted chief operating officer Kim Innes to general manager of its UK and Ireland business, succeeding Richard Daniell. ... She became head of Teva's generics business unit in the UK in 2006,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Wave Healthcare Communications
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
